6-31779239-C-T

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_006295.3(VARS1):​c.3454G>A​(p.Gly1152Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000688 in 1,452,990 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 6.9e-7 ( 0 hom. )

Consequence

VARS1
NM_006295.3 missense

Scores

1
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.117

Publications

0 publications found
Variant links:
Genes affected
VARS1 (HGNC:12651): (valyl-tRNA synthetase 1) Aminoacyl-tRNA synthetases catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAs, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. The protein encoded by this gene belongs to class-I aminoacyl-tRNA synthetase family and is located in the class III region of the major histocompatibility complex. [provided by RefSeq, Jul 2008]
VARS1 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Illumina
  • combined oxidative phosphorylation defect type 20
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.06209144).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VARS1NM_006295.3 linkc.3454G>A p.Gly1152Ser missense_variant Exon 29 of 30 ENST00000375663.8 NP_006286.1 P26640-1A0A024RCN6
VARS1XM_005249362.3 linkc.3457G>A p.Gly1153Ser missense_variant Exon 29 of 30 XP_005249419.1
VARS1XM_047419296.1 linkc.3457G>A p.Gly1153Ser missense_variant Exon 28 of 29 XP_047275252.1
VARS1XM_047419297.1 linkc.3454G>A p.Gly1152Ser missense_variant Exon 28 of 29 XP_047275253.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VARS1ENST00000375663.8 linkc.3454G>A p.Gly1152Ser missense_variant Exon 29 of 30 1 NM_006295.3 ENSP00000364815.3 P26640-1
VARS1ENST00000463184.1 linkn.610G>A non_coding_transcript_exon_variant Exon 3 of 3 2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
6.88e-7
AC:
1
AN:
1452990
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
723116
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33468
American (AMR)
AF:
0.0000225
AC:
1
AN:
44518
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26060
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39646
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86104
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
45996
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5762
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111296
Other (OTH)
AF:
0.00
AC:
0
AN:
60140
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Mar 23, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.3454G>A (p.G1152S) alteration is located in exon 29 (coding exon 28) of the VARS gene. This alteration results from a G to A substitution at nucleotide position 3454, causing the glycine (G) at amino acid position 1152 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.64
CADD
Benign
7.2
DANN
Benign
0.72
DEOGEN2
Benign
0.0022
T
Eigen
Benign
-1.0
Eigen_PC
Benign
-0.90
FATHMM_MKL
Benign
0.62
D
M_CAP
Benign
0.012
T
MetaRNN
Benign
0.062
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
0.29
N
PhyloP100
0.12
PrimateAI
Uncertain
0.65
T
PROVEAN
Benign
0.20
N
REVEL
Benign
0.040
Sift
Benign
0.86
T
Sift4G
Benign
0.79
T
Polyphen
0.0
B
Vest4
0.079
MutPred
0.29
Gain of glycosylation at G1152 (P = 0.0246);
MVP
0.16
MPC
0.45
ClinPred
0.044
T
GERP RS
3.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2
Varity_R
0.047
gMVP
0.44
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1300555678; hg19: chr6-31747016; API